Expanded Access to Convalescent Plasma for Treatment of COVID-19
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
- Status
- TERMINATED
- Phase
- PHASE2
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention
- Status
- UNKNOWN
- Phase
- NA
Telemedicine in Outpatient Covid-19 Patients
- Status
- UNKNOWN
- Phase
- NA
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluating Clinical Parameters of COVID-19 in Pregnancy
- Status
- UNKNOWN
- Phase
- N/A
Relation Between Lab Finding and COVID-19 Severity
- Status
- UNKNOWN
- Phase
- N/A
Elmo Respiratory Support Project - COVID-19
- Status
- COMPLETED
- Phase
- NA
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
- Status
- COMPLETED
- Phase
- NA
Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
The Heart Hive COVID-19 Study
- Status
- COMPLETED
- Phase
- N/A
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE4
Antiviral Agents Against COVID-19 Infection
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1